Amedeo Smart

Free Medical Literature Service

 

Amedeo

Asthma
  Free Subscription

Articles published in
Ann Allergy Asthma Immunol
    April 2024
  1. TURI KN, Li Y, Xu Y, Gebretsadik T, et al
    The Association of Infant Urinary Adrenal Steroids with the Risk of Childhood Asthma Development.
    Ann Allergy Asthma Immunol. 2024 Apr 15:S1081-1206(24)00215.
    >> Share

  2. WOO SD, Park HS, Yang EM, Ban GY, et al
    8-Iso-prostaglandin F2alpha as a biomarker of T2-low airway inflammation and remodeling in adult asthma.
    Ann Allergy Asthma Immunol. 2024 Apr 12:S1081-1206(24)00214.
    >> Share

    March 2024
  3. MOTA D, Martins C, Puga N, Moreira A, et al
    Asthma and allergy screening in elite football athletes: is it worth it?
    Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00205.
    >> Share

  4. LEE PH, An M, Hwang D, Jang AS, et al
    Impact of circulating angiomotin and angiostatin on clinical variables in patients with asthma.
    Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00207.
    >> Share

  5. HUANG D, Zhang L, Liu Y, Wang J, et al
    Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma.
    Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00150.
    >> Share

  6. ZAHRAEI HN, Schleich F, Louis G, Gerday S, et al
    Evidence for two clusters among non-eosinophilic asthmatics.
    Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00154.
    >> Share

  7. CHIPPS BE, Zeiger RS, Beuther DA, Wise RA, et al
    Advancing assessment of asthma control with a composite tool: the Asthma Impairment and Risk Questionnaire.
    Ann Allergy Asthma Immunol. 2024 Mar 15:S1081-1206(24)00153.
    >> Share

  8. LI Y, Hong X, Chandran A, Keet CA, et al
    Associations between cord blood acetaminophen biomarkers and childhood asthma with and without allergic comorbidities.
    Ann Allergy Asthma Immunol. 2024 Mar 12:S1081-1206(24)00143.
    >> Share

  9. GWAK DY, Tea JC, Fatima FN, Palka JM, et al
    Contribution of caregiver and child anxiety and depressive symptoms to child asthma-related quality of life.
    Ann Allergy Asthma Immunol. 2024 Mar 6:S1081-1206(24)00141.
    >> Share

    February 2024
  10. CETIN GP, Yilmaz I
    What should be the outcome of biological treatment in asthma: "Remission on Treatment" or "Super-responder".
    Ann Allergy Asthma Immunol. 2024 Feb 23:S1081-1206(24)00103.
    >> Share

  11. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
    Lower paraspinal muscle density is associated with small airway dysfunction in women with persistent asthma.
    Ann Allergy Asthma Immunol. 2024 Feb 22:S1081-1206(24)00089.
    >> Share

  12. YAO Y, Yang Y, Wang J, Yu P, et al
    Proteomic and metabolomic proof of concept for unified airways in chronic rhinosinusitis and asthma.
    Ann Allergy Asthma Immunol. 2024 Feb 19:S1081-1206(24)00084.
    >> Share

  13. NGO SY, Bothwell S, Brinton JT, Anderson WC 3rd, et al
    Preparing Adolescents for Independent Asthma Management: Gaps and Opportunities.
    Ann Allergy Asthma Immunol. 2024 Feb 17:S1081-1206(24)00086.
    >> Share

  14. MCCANN W, Murphy KR, Zeiger RS, Beuther DA, et al
    Assessing Meaningful Change in the Asthma Impairment and Risk Questionnaire.
    Ann Allergy Asthma Immunol. 2024 Feb 16:S1081-1206(24)00085.
    >> Share

  15. AKAMATSU T, Shirai T, Okawa K, Hirai K, et al
    Improved small airway dysfunction in severe asthma with clinical remission by anti-IL-5/IL-5 receptor alpha.
    Ann Allergy Asthma Immunol. 2024 Feb 13:S1081-1206(24)00080.
    >> Share

  16. HAN YY, Rosser F, Acosta-Perez E, Canino G, et al
    Social vulnerability index, poverty, and asthma in a prospective study of Puerto Rican youth.
    Ann Allergy Asthma Immunol. 2024 Feb 5:S1081-1206(24)00075.
    >> Share

    January 2024
  17. BRACKEN AC, Oppenheimer JJ, Mosnaim GS, Rank MA, et al
    Simplifying asthma management in a university setting: a perspective.
    Ann Allergy Asthma Immunol. 2024 Jan 20:S1081-1206(24)00014.
    >> Share

  18. ZHOU X, Sampath V, Nadeau KC
    Effect of Air Pollution on Asthma.
    Ann Allergy Asthma Immunol. 2024 Jan 20:S1081-1206(24)00018.
    >> Share

  19. ROSAS-SALAZAR C, Bacharier LB
    The biologic asthma response score: A blueprint to address biologic failure in severe asthma?
    Ann Allergy Asthma Immunol. 2024;132:7-8.
    >> Share

  20. SHAKER M, Golden DBK
    More than 80 years of excellence and collaboration in allergy ... and just getting started.
    Ann Allergy Asthma Immunol. 2024;132:3-4.
    >> Share

  21. LIEBERMAN JA
    Trials and tribulations of managing pediatric and adolescent asthma.
    Ann Allergy Asthma Immunol. 2024;132:1-2.
    >> Share

    December 2023
  22. AKEL MJ, Camargo CA Jr, Fujiogi M, Hasegawa K, et al
    Lack of health disparities during implementation of hospital-initiated care bundle among hospitalized adults with asthma.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01514.
    >> Share

  23. PEREZ-DE-LLANO L, Scelo G, Canonica GW, Chen W, et al
    Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01508.
    >> Share

  24. CAMARGO CA JR, Rane PB, Beck AF, Wang Y, et al
    Geographic Variation in Disease Burden Among Patients with Severe Persistent Asthma in the United States.
    Ann Allergy Asthma Immunol. 2023 Dec 21:S1081-1206(23)01501.
    >> Share

  25. MOHAN A, Desai B, Lugogo N
    Analyzing Co-morbidities and their Influence on Severe Asthma: Another Missing Piece of the Puzzle Solved?
    Ann Allergy Asthma Immunol. 2023 Dec 20:S1081-1206(23)01500.
    >> Share

  26. ADGENT MA, Buth E, Norona-Zhou A, Szpiro AA, et al
    Maternal stressful life events during pregnancy and childhood asthma and wheeze.
    Ann Allergy Asthma Immunol. 2023 Dec 18:S1081-1206(23)01498.
    >> Share

  27. CHU DK, Schneider L, Asiniwasis RN, Boguniewicz M, et al
    Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.
    Ann Allergy Asthma Immunol. 2023 Dec 18:S1081-1206(23)01455.
    >> Share

  28. ANAGNOSTOU A, Greenhawt M, Shaker M
    Improving Food Allergy Management: Control Asthma and Decrease Food Allergy Risk.
    Ann Allergy Asthma Immunol. 2023 Dec 12:S1081-1206(23)01495.
    >> Share

  29. STEPPE S, Stokes DC, Underhill C, Winders TA, et al
    Changing High-Risk Asthma in Memphis Through Partnership: Results from the CHAMP Program.
    Ann Allergy Asthma Immunol. 2023 Dec 9:S1081-1206(23)01486.
    >> Share

  30. SIRCAR K, Hagen MB, Prezzato E, Hsu J, et al
    Opportunities to monitor disparities in asthma and other respiratory diseases using public health data.
    Ann Allergy Asthma Immunol. 2023;131:683-684.
    >> Share

  31. GRAYSON MH
    Congratulations to the 2023 American College of Allergy, Asthma and Immunology Annals Fellow-in-Training award winners.
    Ann Allergy Asthma Immunol. 2023;131:681-682.
    >> Share

    November 2023
  32. PETERS AT, Sagara H, Corren J, Domingo C, et al
    Impact of dupilumab across seasons in patients with type 2 uncontrolled, moderate-to-severe asthma.
    Ann Allergy Asthma Immunol. 2023 Nov 25:S1081-1206(23)01470.
    >> Share

  33. SHERENIAN M, Biagini JM, Ryan P, Hershey GKK, et al
    What allergist/immunologists can do to limit the effects of air pollution on asthma and allergies.
    Ann Allergy Asthma Immunol. 2023 Nov 24:S1081-1206(23)01468.
    >> Share

  34. YANG Y, Kimura H, Yokota I, Makita H, et al
    Applicable predictive factors extracted from peak flow trajectory for the prediction of asthma exacerbation.
    Ann Allergy Asthma Immunol. 2023 Nov 23:S1081-1206(23)01464.
    >> Share

  35. KIM BE, Hui-Beckman JW, Nevid MZ, Goleva E, et al
    Air pollutants contribute to epithelial barrier dysfunction and allergic diseases.
    Ann Allergy Asthma Immunol. 2023 Nov 23:S1081-1206(23)01462.
    >> Share

  36. COREY KB, Moore R, Zuckerman AD, Littlejohn M, et al
    Persistent use of dupilumab in adults with asthma or chronic rhinosinusitis with nasal polyps.
    Ann Allergy Asthma Immunol. 2023 Nov 17:S1081-1206(23)01454.
    >> Share

  37. PHAM DD, Lee JH, Kwon HS, Song WJ, et al
    Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.
    Ann Allergy Asthma Immunol. 2023 Nov 15:S1081-1206(23)01402.
    >> Share

  38. BLAISS M, Bleecker ER, Jacob-Nara J, Nair R, et al
    Real-world effectiveness of dupilumab in patients with asthma: findings from the United States ADVANTAGE study.
    Ann Allergy Asthma Immunol. 2023 Nov 13:S1081-1206(23)01399.
    >> Share

  39. AGARWAL CD, Palka JM, Gajewski AJ, Khan DA, et al
    The Efficacy of Citalopram or Escitalopram in Patients with Asthma and Major Depressive Disorder.
    Ann Allergy Asthma Immunol. 2023 Nov 10:S1081-1206(23)01401.
    >> Share

  40. GEVAERT P, Mullol J, Saenz R, Ko J, et al
    Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
    Ann Allergy Asthma Immunol. 2023 Nov 9:S1081-1206(23)01393.
    >> Share

  41. CHEN M, Bacong AM, Feng C, Kikuta NT, et al
    Asthma heterogeneity amongst Asian American children: the California Health Interview Survey.
    Ann Allergy Asthma Immunol. 2023 Nov 8:S1081-1206(23)01395.
    >> Share

  42. XU J, Rathkopf MM
    The cost of medication costs: Cost-related medication nonadherence in patients with asthma in the United States.
    Ann Allergy Asthma Immunol. 2023;131:538-539.
    >> Share

    October 2023
  43. PATEL D, Revier MD, Tambay A, Geng B, et al
    Implementation of a Pediatric Synchronous Multidisciplinary Severe Asthma Clinic and Real-World Outcomes.
    Ann Allergy Asthma Immunol. 2023 Oct 26:S1081-1206(23)01380.
    >> Share

  44. HO JK, Shaker M, Greenhawt M, Sadatsafavi M, et al
    Cost-effectiveness of budesonide-formoterol versus inhaled epinephrine in United States adults with mild asthma.
    Ann Allergy Asthma Immunol. 2023 Oct 23:S1081-1206(23)01352.
    >> Share

  45. JOHNSON KM, Cheng L, Yin Y, Carter R, et al
    Impact of income-based public drug coverage deductibles on adherence to asthma medications.
    Ann Allergy Asthma Immunol. 2023 Oct 21:S1081-1206(23)01345.
    >> Share

  46. YOSHIZATO R, Motomura Y, Fujita T, Babazono A, et al
    Secondhand smoking and pediatric asthma after respiratory syncytial virus or human metapneumovirus infection.
    Ann Allergy Asthma Immunol. 2023 Oct 18:S1081-1206(23)01342.
    >> Share

  47. KILPATRICK K, Ambrose CS, Lindsley AW, Oppenheimer J, et al
    At-Home Asthma Mortality Unchanged Despite Declining Mortality in Other Settings: US Death Certificate Data (2000-2019).
    Ann Allergy Asthma Immunol. 2023 Oct 15:S1081-1206(23)01315.
    >> Share

  48. CHAN R, Lipworth B
    Characterising moderate-to-severe asthma patients with preserved small airway function.
    Ann Allergy Asthma Immunol. 2023 Oct 10:S1081-1206(23)01306.
    >> Share

  49. AVERILL SH, Forno E
    Management of the Pediatric Patient with Asthma and Obesity.
    Ann Allergy Asthma Immunol. 2023 Oct 10:S1081-1206(23)01301.
    >> Share

  50. SHAKER M, Abrams EM, Sublett JW
    Corrigendum to "Contextual community epinephrine prescribing: Is more always better?" [Ann Allergy Asthma Immunol 131 (2023) 176-184].
    Ann Allergy Asthma Immunol. 2023;131:534.
    >> Share

  51. COSCIA G
    Asthma control questionnaires: A broader perspective.
    Ann Allergy Asthma Immunol. 2023;131:405-406.
    >> Share

  52. HERZBERG SD, Bosso AM, Sangal NR, Bosso JV, et al
    Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2023;131:528-530.
    >> Share

    September 2023
  53. BLAISS M, Oppenheimer J, Corbett M, Bacharier L, et al
    Consensus of an ACAAI, AAAAI, and ATS Workgroup on Definition of Clinical Remission in Asthma on Treatment.
    Ann Allergy Asthma Immunol. 2023 Sep 8:S1081-1206(23)01218.
    >> Share

  54. GRAYSON MH, Williams PV
    Defining remission in asthma care.
    Ann Allergy Asthma Immunol. 2023 Sep 7:S1081-1206(23)01217.
    >> Share

  55. HUNT KM, Foley M, Connors LA, Hildebrand KJ, et al
    Trends in the Proportion of Women Speakers at North American Allergy & Immunology Conferences, 2008-2020.
    Ann Allergy Asthma Immunol. 2023 Sep 7:S1081-1206(23)01215.
    >> Share

  56. KIM SL, Rank MA, Peters AT
    The chronic rhinosinusitis practice parameter.
    Ann Allergy Asthma Immunol. 2023;131:307-310.
    >> Share

  57. SUPRON AD, Bergmark RW, Roditi RE, Buchheit KM, et al
    Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth.
    Ann Allergy Asthma Immunol. 2023;131:384-386.
    >> Share

  58. RAMOS CL, Thakrar H, Walters K, Waldram J, et al
    Characterization of alcohol-induced respiratory symptoms in aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2023;131:382-384.
    >> Share

  59. MULLUR J, Buchheit KM
    Aspirin-exacerbated respiratory disease: Updates in the era of biologics.
    Ann Allergy Asthma Immunol. 2023;131:317-324.
    >> Share

  60. NAEGER S, Macina D, Pool V
    Tetanus, diphtheria, and acellular pertussis vaccine coverage in adults with chronic respiratory conditions.
    Ann Allergy Asthma Immunol. 2023;131:333-337.
    >> Share

    August 2023
  61. SCHEPEL IRM, Banzon TM, Phipatanakul W
    Future of Biologics in Pediatric Asthma: Optimizing Response, Early Introduction, and Equitable Access to Treatment.
    Ann Allergy Asthma Immunol. 2023 Aug 29:S1081-1206(23)01207.
    >> Share

  62. PERSAUD PN, Tran AP, Messner D, Thornton JD, et al
    Perception of burden of oral and inhaled corticosteroid adverse effects on asthma-specific quality of life.
    Ann Allergy Asthma Immunol. 2023 Aug 27:S1081-1206(23)00636.
    >> Share

  63. SCELO G, Torres-Duque CA, Maspero J, Tran TN, et al
    Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
    Ann Allergy Asthma Immunol. 2023 Aug 26:S1081-1206(23)00630.
    >> Share

  64. GALANT SP, Morphew T
    Adding oscillometry to spirometry in guidelines better identifies uncontrolled asthma, future exacerbations, potential targeted therapy.
    Ann Allergy Asthma Immunol. 2023 Aug 23:S1081-1206(23)00587.
    >> Share

  65. PAVORD ID, Hoyte FCL, Lindsley AW, Ambrose CS, et al
    Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).
    Ann Allergy Asthma Immunol. 2023 Aug 22:S1081-1206(23)00593.
    >> Share

  66. GAFFNEY A, Himmelstein DU, Woolhandler S
    Population-Level Trends in Asthma and COPD Emergency Department Visits and Hospitalizations Before and During the COVID-19 Pandemic in the US.
    Ann Allergy Asthma Immunol. 2023 Aug 22:S1081-1206(23)00591.
    >> Share

  67. HUI-BECKMAN J, Goleva E, Leung DYM, Kim BE, et al
    The impact of temperature on the skin barrier and atopic dermatitis.
    Ann Allergy Asthma Immunol. 2023 Aug 16:S1081-1206(23)00569.
    >> Share

  68. WISNIVESKY JP, Agrawal N, Ankam J, Gonzalez A, et al
    World Trade Center Workers with Asthma and PTSD More Accurately Perceive Airflow Limitation.
    Ann Allergy Asthma Immunol. 2023 Aug 12:S1081-1206(23)00568.
    >> Share

  69. KAYSER MZ, Julicher BL, Welte T, Fuge J, et al
    Retrospective Analysis and Biologic Asthma Response Score reveal roadmap for switching biologics in severe asthma.
    Ann Allergy Asthma Immunol. 2023 Aug 12:S1081-1206(23)00567.
    >> Share

  70. AVDEEV SN, Gaynitdinova VV, Pozdnakova AA, Yu Chikina S, et al
    Asthma in elderly and COVID-19: results of 90-day post-hospital follow-up.
    Ann Allergy Asthma Immunol. 2023 Aug 7:S1081-1206(23)00564.
    >> Share

  71. HSU CS, Chen YM, Hsu CY, Deng YL, et al
    Diabetes Mellitus and Bone Mineral Density on Fracture Risk in Allergic Rhinitis and Asthma Patients.
    Ann Allergy Asthma Immunol. 2023 Aug 7:S1081-1206(23)00565.
    >> Share

  72. KOENIGSBERG R, Grayson MH
    Did the coronavirus disease 2019 pandemic change asthma prevalence?
    Ann Allergy Asthma Immunol. 2023;131:141-142.
    >> Share

    July 2023
  73. CHAN R, Lipworth B
    Real life effects of dupilumab on airway oscillometry in severe uncontrolled asthma.
    Ann Allergy Asthma Immunol. 2023 Jul 28:S1081-1206(23)00558.
    >> Share

  74. LEDFORD DK, Soong W, Carr W, Trevor J, et al
    Real-world Severe Asthma Biologic Administration and Adherence Differs by Biologic: CHRONICLE Study Results.
    Ann Allergy Asthma Immunol. 2023 Jul 26:S1081-1206(23)00522.
    >> Share

  75. XIA T, Qiu H, Yu B, Bi J, et al
    Cost-Related Medication Nonadherence In U.S. Adults With Asthma: The National Health Interview Survey 2013-2020.
    Ann Allergy Asthma Immunol. 2023 Jul 25:S1081-1206(23)00518.
    >> Share

  76. UGALDE IC, Ratigan A, Merriman C, Cui J, et al
    Preference for and Impact of Telehealth vs. In-person Asthma Visits Among Black and Latinx Adults.
    Ann Allergy Asthma Immunol. 2023 Jul 23:S1081-1206(23)00520.
    >> Share

  77. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
    An asthma phenotype comprising bronchial wall thickening and mucus plugging confers worse clinical outcomes.
    Ann Allergy Asthma Immunol. 2023 Jul 18:S1081-1206(23)00500.
    >> Share

  78. MOSNAIM G
    Can we improve adherence and asthma outcomes in children and adolescents with technology-based interventions?
    Ann Allergy Asthma Immunol. 2023 Jul 9:S1081-1206(23)00493.
    >> Share

  79. ZAEH SE, Chupp G, Eakin MN
    Is there a Best Strategy to Prevent Asthma Exacerbations in Inner City Asthmatics?
    Ann Allergy Asthma Immunol. 2023 Jul 9:S1081-1206(23)00492.
    >> Share

  80. LAU HX, Chen Z, Bever HV, Tham EH, et al
    Clinical predictors of wheeze trajectories and associations with allergy in Asian children.
    Ann Allergy Asthma Immunol. 2023 Jul 5:S1081-1206(23)00485.
    >> Share

  81. SANTIAGO DVH, Fagbamigbe DAF, Sullivan PF, Agrawal DU, et al
    Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study.
    Ann Allergy Asthma Immunol. 2023 Jul 4:S1081-1206(23)00487.
    >> Share

  82. BELLANTI JA, Schroer B, Marshall GD Jr, Grayson MH, et al
    The 80th anniversary of Annals of Allergy, Asthma & Immunology (1943-2023).
    Ann Allergy Asthma Immunol. 2023;131:128-130.
    >> Share

  83. MENDOZA J, Carlson G, Nath P, Quinn J, et al
    A look at adherence with subcutaneous immunotherapy without out-of-pocket patient costs.
    Ann Allergy Asthma Immunol. 2023;131:96-100.
    >> Share

    June 2023
  84. LANZ MJ, Gilbert IA, Gandhi HN, Pollack M, et al
    Patterns of rescue and maintenance therapy claims surrounding a clinical encounter for an asthma exacerbation.
    Ann Allergy Asthma Immunol. 2023 Jun 19:S1081-1206(23)00441.
    >> Share

  85. LARENAS-LINNEMANN D, Romeo J, Ariue B, Oppenheimer J, et al
    ACAAI members' preferred step 1-3 asthma maintenance and reliever therapy and incomplete insurance coverage indicated as main practice hurdle.
    Ann Allergy Asthma Immunol. 2023 Jun 14:S1081-1206(23)00407.
    >> Share

  86. KIM I, Morphew T, Chou C, Ehwerhemuepha L, et al
    Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children.
    Ann Allergy Asthma Immunol. 2023 Jun 13:S1081-1206(23)00417.
    >> Share

  87. LEE E, Rhee EH, Kim K, Kim HS, et al
    Frequency of exacerbation and degree of required asthma medication can characterize childhood longitudinal asthma trajectories.
    Ann Allergy Asthma Immunol. 2023 Jun 9:S1081-1206(23)00408.
    >> Share

  88. NGUYEN AT, Settipane RA
    Erratum to "A potpourri of summer allergic environmental disorders" [Ann Allergy Asthma Immunol 130 (2023) 415-418].
    Ann Allergy Asthma Immunol. 2023;130:823.
    >> Share

    May 2023
  89. PHAM DD, Lee JH, Kwon HS, Song WJ, et al
    Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.
    Ann Allergy Asthma Immunol. 2023 May 31:S1081-1206(23)00402.
    >> Share

  90. EKSTEDT S, Lagebro V, Georen SK, Cardell LO, et al
    Prolonged inflammatory resolution in allergic asthma relates to dysfunctional interactions between neutrophils and airway epithelium.
    Ann Allergy Asthma Immunol. 2023 May 31:S1081-1206(23)00400.
    >> Share

  91. MENZIES-GOW A, Bourdin A, Chupp G, Israel E, et al
    Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: the NAVIGATOR study.
    Ann Allergy Asthma Immunol. 2023 May 30:S1081-1206(23)00399.
    >> Share

  92. DEBNATH C, Agarwal S, Atkinson C, Chong LK, et al
    Impact of Race on In-Hospital Outcomes of Patients Hospitalized for Asthma Exacerbation.
    Ann Allergy Asthma Immunol. 2023 May 30:S1081-1206(23)00397.
    >> Share

  93. NAZARIO S, Gonzalez-Sepulveda L, Telon-Sosa B, Rivas-Tumanyan S, et al
    Place of death from asthma differs by age, race and ethnicity.
    Ann Allergy Asthma Immunol. 2023 May 22:S1081-1206(23)00359.
    >> Share

  94. WOO SD, Park HS, Jang JH, Lee Y, et al
    Biomarkers for Predicting Type 2-high and Uncontrolled Asthma in Real-World Practice.
    Ann Allergy Asthma Immunol. 2023 May 18:S1081-1206(23)00339.
    >> Share

  95. CHAN R, Lipworth B
    Clinical impact of obesity on oscillometry lung mechanics in adult asthmatics.
    Ann Allergy Asthma Immunol. 2023 May 18:S1081-1206(23)00341.
    >> Share

  96. BEDOLLA-BARAJAS M, Morales-Romero J, Robles-Figueroa M, Delgado-Figueroa T, et al
    Changes in the national prevalence of asthma and COVID-19 fatality: A population-based cross-sectional study.
    Ann Allergy Asthma Immunol. 2023 May 2:S1081-1206(23)00327.
    >> Share

  97. HANTGAN SL, Jariwala SP
    Erratum to "User-centered mobile health applications for asthma" [Ann Allergy Asthma Immunol 130 (2023) 159-160].
    Ann Allergy Asthma Immunol. 2023;130:692.
    >> Share

  98. GOLDSOBEL AB
    Corrigendum to "Chronic cough comes of age" [Ann Allergy Asthma Immunol 130 (2023) Pages 4-5].
    Ann Allergy Asthma Immunol. 2023;130:692.
    >> Share

  99. GALANT SP
    Could salivary alpha-amylase be a proxy for identifying beta-2 adrenergic induced tolerization in asthma?
    Ann Allergy Asthma Immunol. 2023;130:544-545.
    >> Share

  100. STROTHMAN K
    Choosing biologics for uncontrolled asthma: A conundrum for clinicians.
    Ann Allergy Asthma Immunol. 2023;130:534-535.
    >> Share

    April 2023
  101. LUCAS D, Gourier G, Bygvraa DA, Canals ML, et al
    Occupational allergic diseases among harvesting fishermen at the open sea: a systematic review.
    Ann Allergy Asthma Immunol. 2023 Apr 26:S1081-1206(23)00285.
    >> Share

  102. CHIPPS B, Zeiger RS, Beuther DA, Reibman J, et al
    The Asthma Impairment and Risk Questionnaire Enhances the Assessment of Asthma Control.
    Ann Allergy Asthma Immunol. 2023 Apr 25:S1081-1206(23)00308.
    >> Share

  103. SHEEHAN WJ, Maghzian N, Rastogi D, Bollard CM, et al
    Decreased Regulatory B Cells in Pediatric Patients with Asthma.
    Ann Allergy Asthma Immunol. 2023 Apr 24:S1081-1206(23)00306.
    >> Share

  104. ITO K, Kanemitsu Y, Fukumitsu K, Tajiri T, et al
    Targeting the IL-5 pathway improves cough hypersensitivity in patients with severe uncontrolled asthma.
    Ann Allergy Asthma Immunol. 2023 Apr 24:S1081-1206(23)00310.
    >> Share

  105. LEE JH, Hong C, Oh JS, Kim TB, et al
    Electronic Medical Record-Based Machine Learning Predicts the Relapse of Asthma Exacerbation.
    Ann Allergy Asthma Immunol. 2023 Apr 24:S1081-1206(23)00307.
    >> Share

  106. HONG B, Merrill KA, Golding MA, Simons E, et al
    Pre-hospital epinephrine administration for treating anaphylaxis among those with co-morbid asthma: A scoping review.
    Ann Allergy Asthma Immunol. 2023 Apr 21:S1081-1206(23)00267.
    >> Share

  107. SHANNON CM, Flaherty C, Quarshie WO, Xiao R, et al
    Asthma medication adherence during the COVID-19 pandemic in children at high risk of exacerbation.
    Ann Allergy Asthma Immunol. 2023 Apr 18:S1081-1206(23)00263.
    >> Share

  108. FUKUMITSU K, Kanemitsu Y, Kurokawa R, Takeda N, et al
    Tiotropium for refractory cough in asthma via cough reflex sensitivity: a randomized, parallel, open-label, trial.
    Ann Allergy Asthma Immunol. 2023 Apr 6:S1081-1206(23)00248.
    >> Share

  109. TEAGUE WG
    Analysis of lung lavage granulocyte constituents and blood type 2 biomarkers does not support routine use of corticosteroids in children with problematic wheeze: Reply to: Short courses of oral corticosteroids are effective, important, and safe for vi
    Ann Allergy Asthma Immunol. 2023;130:526.
    >> Share

  110. WEINBERGER M
    Short courses of oral corticosteroids are effective, important, and safe for virus-triggered wheeze.
    Ann Allergy Asthma Immunol. 2023;130:525.
    >> Share

    March 2023
  111. LEE E, Park YM, Lee SY, Lee SH, et al
    Associations of prenatal antibiotic exposure and delivery mode on childhood asthma inception.
    Ann Allergy Asthma Immunol. 2023 Mar 27:S1081-1206(23)00208.
    >> Share

  112. REDDY A, Dunivin G, Garlapati R, Reddy S, et al
    Readability and quality of patient education material for asthma.
    Ann Allergy Asthma Immunol. 2023 Mar 27:S1081-1206(23)00209.
    >> Share

  113. ALI H, Douwes J, Burmanje J, Gokhale P, et al
    Sputum inflammatory, neural, and remodelling mediators in eosinophilic and non-eosinophilic asthma.
    Ann Allergy Asthma Immunol. 2023 Mar 21:S1081-1206(23)00181.
    >> Share

  114. JACKSON DJ, Bacharier LB, Phipatanakul W, Sher L, et al
    Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma.
    Ann Allergy Asthma Immunol. 2023 Mar 21:S1081-1206(23)00180.
    >> Share

  115. HORN A, Bernstein DI, Okubo K, Dalgaard T, et al
    House Dust Mite Sublingual Immunotherapy Tablet Safety in Adolescents with Allergic Rhinoconjunctivitis: Clinical Trial Results.
    Ann Allergy Asthma Immunol. 2023 Mar 14:S1081-1206(23)00171.
    >> Share

  116. CHIPPS BE, Soong W, Panettieri RA Jr, Carr W, et al
    Number of patient-reported asthma triggers predicts uncontrolled disease among specialist-treated patients with severe asthma.
    Ann Allergy Asthma Immunol. 2023 Mar 9:S1081-1206(23)00165.
    >> Share

  117. GUTWEIN A, Han YY, Colon-Semidey A, Alvarez M, et al
    Low parental numeracy and severe asthma exacerbations in a prospective study of Puerto Rican youth.
    Ann Allergy Asthma Immunol. 2023 Mar 7:S1081-1206(23)00166.
    >> Share

  118. VOLERMAN A, Balachandran U, Zhu M, Akel M, et al
    Evaluating Inhaler Education Interventions for Hospitalized Children with Asthma: A Randomized Controlled Trial.
    Ann Allergy Asthma Immunol. 2023 Mar 2:S1081-1206(23)00131.
    >> Share

  119. ACEVES SS, Dellon ES, Greenhawt M, Hirano I, et al
    Clinical guidance for the use of dupilumab in eosinophilic esophagitis: A yardstick.
    Ann Allergy Asthma Immunol. 2023;130:371-378.
    >> Share

    February 2023
  120. CHAN R, Lipworth B
    Efficacy of biologic therapy on airway hyperresponsiveness in asthma.
    Ann Allergy Asthma Immunol. 2023 Feb 23:S1081-1206(23)00121.
    >> Share

  121. LEDFORD DK
    Self-Contained Underwater Breathing Apparatus (SCUBA) Diving and Asthma: Where are we in 2023?
    Ann Allergy Asthma Immunol. 2023 Feb 17:S1081-1206(23)00046.
    >> Share

  122. STICKLER MB, Hamilton RG, Cooke RK, Bollinger ME, et al
    An emerging new respiratory pathogen, Lophomonas blattarum, found in bronchoalveolar lavage in an immunodeficient patient with asthma.
    Ann Allergy Asthma Immunol. 2023 Feb 13:S1081-1206(23)00091.
    >> Share

  123. KAMAN K, Dhodapkar M, Shabanova V, McCollum S, et al
    Validated Anxiety Assessments Among Pediatric Peanut-Allergic Patients on Oral Immunotherapy.
    Ann Allergy Asthma Immunol. 2023 Feb 2:S1081-1206(23)00080.
    >> Share

  124. PANDYA A, Portnoy J
    Does improved indoor air quality lead to better asthma control?
    Ann Allergy Asthma Immunol. 2023;130:147-148.
    >> Share

  125. BORISH L, Teague WG, Patrie JT, Wavell KW, et al
    Further evidence of a type 2 inflammatory signature in chronic obstructive pulmonary disease or emphysema.
    Ann Allergy Asthma Immunol. 2023 Feb 1:S1081-1206(23)00078.
    >> Share

    January 2023
  126. HOLLENBACH JP, Collins MS, Wasser C, Fedele D, et al
    Implementation of standardized asthma management programs in outpatient settings.
    Ann Allergy Asthma Immunol. 2023 Jan 23:S1081-1206(23)00041.
    >> Share

  127. OPPENHEIMER J, Borish L
    Operationalization of Dynamic Dosing in Asthma.
    Ann Allergy Asthma Immunol. 2023 Jan 17:S1081-1206(23)00008.
    >> Share

  128. SUZUKAWA M, Ohta K, Hashimoto H, Oyamada Y, et al
    Characterization and cluster analyses of elderly asthma in comparison with non-elderly asthma patients in Japan.
    Ann Allergy Asthma Immunol. 2023 Jan 16:S1081-1206(23)00005.
    >> Share

  129. GALANT SP, Morphew T
    IN YOUNG ASTHMATIC CHILDREN, OBESITY AND UNCONTROLLED DISEASE ARE HIGHLY ASSOCIATED WITH PERIPHERAL AIRWAY IMPAIRMENT.
    Ann Allergy Asthma Immunol. 2023 Jan 13:S1081-1206(23)00004.
    >> Share

  130. GOLDSOBEL AB
    Chronic cough comes of age.
    Ann Allergy Asthma Immunol. 2023;130:4-5.
    >> Share

  131. NEAVES BI, Adams KE, White KM, Stokes SC, et al
    Long-term adherence to imported fire ant subcutaneous immunotherapy.
    Ann Allergy Asthma Immunol. 2023;130:106-110.
    >> Share

    December 2022
  132. PITRE T, Jassal T, Angjeli A, Jarabana V, et al
    A comparison of the effectiveness of biologic therapies for asthma:a systematic review and network meta-analysis.
    Ann Allergy Asthma Immunol. 2022 Dec 20:S1081-1206(22)02000.
    >> Share

  133. CORBETT M, Allen A, Bobo N, Foggs MB, et al
    Proceedings of a Roundtable Conducted by the American College of Allergy, Asthma & Immunology on Racial Disparities in Atopic Dermatitis and Food Allergy.
    Ann Allergy Asthma Immunol. 2022 Dec 17:S1081-1206(22)02001.
    >> Share

  134. CHEN JH, Orden T, Wang J, Sowho M, et al
    Risk of anaphylaxis in cluster versus standard subcutaneous multi-allergen immunotherapy.
    Ann Allergy Asthma Immunol. 2022 Dec 12:S1081-1206(22)01993.
    >> Share

  135. CHAN R, Lipworth B
    Severe asthma with fungal sensitisation is associated with worse small airways dysfunction but similar symptom control.
    Ann Allergy Asthma Immunol. 2022 Dec 10:S1081-1206(22)01987.
    >> Share

  136. SHER LD, Passalacqua G, Taille C, Cohn L, et al
    Long-term effect of dupilumab on dyspnea, sleep, and activity in oral corticosteroid-dependent severe asthma.
    Ann Allergy Asthma Immunol. 2022 Dec 9:S1081-1206(22)01983.
    >> Share

  137. INSELMAN JW, Jeffery MM, Maddux JT, Lam RW, et al
    A prediction model for asthma exacerbations after stopping asthma biologics.
    Ann Allergy Asthma Immunol. 2022 Dec 9:S1081-1206(22)01972.
    >> Share

  138. CHAN R, Duraikannu C, Lipworth B
    Clinical characteristics of the asthma bronchiectasis phenotype.
    Ann Allergy Asthma Immunol. 2022 Dec 8:S1081-1206(22)01984.
    >> Share

  139. MAKIN T, Breidenbaugh M, Borish L
    Novel insights into pathogenic mechanisms of severe exacerbation-prone asthma and their impact on clinical management.
    Ann Allergy Asthma Immunol. 2022;129:651-652.
    >> Share

  140. GRAYSON MH
    Announcing the 2022 American College of Allergy, Asthma and Immunology Annals fellow-in-training award winners.
    Ann Allergy Asthma Immunol. 2022;129:649-650.
    >> Share

  141. TEAGUE WG
    Lung lavage inflammatory patterns and pathogen profiles in preschool children with problematic wheeze.
    Ann Allergy Asthma Immunol. 2022;129:674-675.
    >> Share

    November 2022
  142. KHAN DA
    The best of 2022 American College of Allergy, Asthma, and Immunology literature review.
    Ann Allergy Asthma Immunol. 2022 Nov 29:S1081-1206(22)01901.
    >> Share

  143. LI C, Zhang B, Yan M, Li Y, et al
    Cluster Analysis of Patients with Chronic Rhinosinusitis and Asthma after Endoscopic Sinus Surgery.
    Ann Allergy Asthma Immunol. 2022 Nov 24:S1081-1206(22)01955.
    >> Share

  144. RIEDL MA
    Update on skin diseases: Urticaria, angioedema, and other skin disorders from the 2022 American College of Allergy, Asthma, and Immunology Annual Literature Review.
    Ann Allergy Asthma Immunol. 2022 Nov 23:S1081-1206(22)01913.
    >> Share

  145. HANTGAN SL, Jariwala SP
    User-centered mobile health applications for asthma.
    Ann Allergy Asthma Immunol. 2022 Nov 15. pii: S1081-1206(22)01917.
    >> Share

  146. ZHANG X, Xu Z, Lin J, Xie G, et al
    Sex differences of small airway function and FeNO in patients with mild asthma.
    Ann Allergy Asthma Immunol. 2022 Nov 15. pii: S1081-1206(22)01916.
    >> Share

  147. BERGER P, Menzies-Gow A, Peters AT, Kuna P, et al
    Long-term efficacy of dupilumab in asthma with and without chronic rhinosinusitis and/or nasal polyps.
    Ann Allergy Asthma Immunol. 2022 Nov 7. pii: S1081-1206(22)01912.
    >> Share

  148. GREINER B, Cronin K, Salazar L, Hartwell M, et al
    Asthma related disparities in emergency department usage and clinical outcomes among Spanish speaking Hispanic patients.
    Ann Allergy Asthma Immunol. 2022 Nov 7. pii: S1081-1206(22)01909.
    >> Share

  149. HANANIA NA, Castro M, Bateman E, Pavord ID, et al
    Efficacy of Dupilumab in Patients with Moderate-to-Severe Asthma and Persistent Airflow Obstruction.
    Ann Allergy Asthma Immunol. 2022 Nov 1. pii: S1081-1206(22)01899.
    >> Share

  150. GHIASI Y, Wangberg H, Bagsic SRS, White A, et al
    Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2022;129:642-643.
    >> Share

    October 2022
  151. FONG WCG, Kadalayil L, Lowther S, Grevatt S, et al
    Efficacy of Dyson air purifier on asthma control: a single-center, investigator-led, randomized, double-blind, placebo-controlled trial.
    Ann Allergy Asthma Immunol. 2022 Oct 23. pii: S1081-1206(22)01850.
    >> Share

  152. MCCULLOCH MR, Thomas JF, Thompson MA, Carel KD, et al
    Outpatient Electronic Consultations in Pediatric Allergy/Immunology.
    Ann Allergy Asthma Immunol. 2022 Oct 8. pii: S1081-1206(22)01827.
    >> Share

  153. LI JT
    Asthma chronic obstructive pulmonary disease and lower respiratory disorders.
    Ann Allergy Asthma Immunol. 2022 Oct 6:S1081-1206(22)01727.
    >> Share

  154. WEINBERGER M
    Can current hospitalization rates for asthma be decreased?
    Ann Allergy Asthma Immunol. 2022;129:401-402.
    >> Share

  155. WEINBERGER M
    Should asthma evaluation include assessment of small airway function?
    Ann Allergy Asthma Immunol. 2022;129:399-400.
    >> Share

  156. COLAK Y, Ingebrigtsen TS, Nordestgaard BG, Marott JL, et al
    Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohort.
    Ann Allergy Asthma Immunol. 2022;129:490-496.
    >> Share

    September 2022
  157. CHAN R, Stewart K, Lipworth B
    Airflow obstruction in real life is associated with small airways dysfunction in moderate to severe asthma.
    Ann Allergy Asthma Immunol. 2022 Sep 24. pii: S1081-1206(22)01775.
    >> Share

  158. SANGKANJANAVANICH S, Pradubpongsa P, Mitthamsiri W, Sangasapaviliya A, et al
    Bifidobacterium infantis 35624 Efficacy in Patients with Uncontrolled Asthma: A Randomized Placebo-Controlled Trial.
    Ann Allergy Asthma Immunol. 2022 Sep 8. pii: S1081-1206(22)01712.
    >> Share

    August 2022
  159. BIGGS SE, Ownby DR, May KR
    Use of over-the-counter inhaled epinephrine in asthma.
    Ann Allergy Asthma Immunol. 2022 Aug 27. pii: S1081-1206(22)01674.
    >> Share

  160. PRICE AS, Kennedy JL
    T helper 2 Mechanisms involved in Human Rhinovirus Infections and Asthma.
    Ann Allergy Asthma Immunol. 2022 Aug 21. pii: S1081-1206(22)00695.
    >> Share

  161. LIU J, Yuan MB, Chen YQ, Wang Y, et al
    Global burden of asthma associated with high body mass index from 1990 to 2019.
    Ann Allergy Asthma Immunol. 2022 Aug 21. pii: S1081-1206(22)00694.
    >> Share

  162. CHOW TG, Palka JM, Stone B, Trojan T, et al
    Safety of Subcutaneous Immunotherapy in Patients with Severe Asthma.
    Ann Allergy Asthma Immunol. 2022 Aug 20. pii: S1081-1206(22)00693.
    >> Share

  163. COLETTA C, Grayson MH
    Causation or coincidence? Phenotype of asthma exacerbations during the coronavirus disease 2019 pandemic.
    Ann Allergy Asthma Immunol. 2022;129:131-132.
    >> Share

    July 2022
  164. BRYANT N, Muehling LM
    T-cell responses in asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Jul 30. pii: S1081-1206(22)00621.
    >> Share

  165. IMAM SF, Zafar S, Oppenheimer J
    SMART in treatment of asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Jul 29. pii: S1081-1206(22)00619.
    >> Share

  166. GREINER B, Hartwell M
    Prevalence and associations between metabolically unhealthy obesity and asthma exacerbations and emergency department usage.
    Ann Allergy Asthma Immunol. 2022 Jul 14. pii: S1081-1206(22)00590.
    >> Share

  167. PATE CA, Zahran HS, Malilay J, Hsu J, et al
    The Shifting Prevalence of Asthma and Allergic Disease in United States Children.
    Ann Allergy Asthma Immunol. 2022 Jul 13. pii: S1081-1206(22)00586.
    >> Share

    June 2022
  168. LEE TY, Petkau J, Mangat N, Safari A, et al
    16-year trends in asthma hospital admissions in Canada.
    Ann Allergy Asthma Immunol. 2022 Jun 29. pii: S1081-1206(22)00540.
    >> Share

  169. DINWIDDIE DL, Kaukis N, Pham S, Hardin O, et al
    Viral infection and allergy status impact severity of asthma symptoms in children with asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Jun 21. pii: S1081-1206(22)00535.
    >> Share

  170. PANETTIERI RA JR, Ledford DK, Chipps BE, Soong W, et al
    Biologic Use and Outcomes Among Adults with Severe Asthma Treated by United States Subspecialists.
    Ann Allergy Asthma Immunol. 2022 Jun 18. pii: S1081-1206(22)00532.
    >> Share

  171. POLIVKA BJ, Huntington-Moskos L, Antimisiaris DE, Cavallazzi RS, et al
    Phenotyping Older Adults with Asthma via Cluster Analysis.
    Ann Allergy Asthma Immunol. 2022 Jun 10. pii: S1081-1206(22)00501.
    >> Share

  172. RURAN HB, Maciag MC, Murphy SE, Phipatanakul W, et al
    Cross-Sectional Study of Urinary Biomarkers of Environmental Tobacco and E-Cigarette Exposure and Asthma Morbidity.
    Ann Allergy Asthma Immunol. 2022 Jun 7. pii: S1081-1206(22)00499.
    >> Share

  173. BELLANTI JA, Lanier BQ, Ein D, Finegold I, et al
    The American College of Allergy, Asthma & Immunology: an 80-year legacy of accomplishments (1942-2022), part 3: events and achievements (2012-2022).
    Ann Allergy Asthma Immunol. 2022 Jun 4. pii: S1081-1206(22)00494.
    >> Share

  174. CHUNG Y, Katial R, Mu F, Cook EE, et al
    Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study.
    Ann Allergy Asthma Immunol. 2022;128:669-676.
    >> Share

    May 2022
  175. SCIOSCIA BG, Lacedonia D, Quarato CMI, Tondo P, et al
    Could Transthoracic Ultrasound be useful to suggest a small airways disease in severe uncontrolled asthma?
    Ann Allergy Asthma Immunol. 2022 May 25. pii: S1081-1206(22)00491.
    >> Share

  176. CHUPP G, Wechsler ME
    Biologic Medications in Asthma: What have we learned from long-term studies?
    Ann Allergy Asthma Immunol. 2022 May 24. pii: S1081-1206(22)00489.
    >> Share

  177. WANG EA, Goleva E, Ketosugbo K, Kern JA, et al
    Effect of immune checkpoint inhibitors on asthma.
    Ann Allergy Asthma Immunol. 2022 May 24. pii: S1081-1206(22)00487.
    >> Share

  178. LIPWORTH DB, Stewart MK, Chan DR
    Pragmatic reappraisal of long acting muscarinic antagonists at steps 4/5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology.
    Ann Allergy Asthma Immunol. 2022 May 22. pii: S1081-1206(22)00449.
    >> Share

  179. HUDDLESTON CM, Slaven JE, Weist AD, Krupp NL, et al
    Increased Healthcare Utilization in Moderate to Severe Asthma Patients Due to Frequent Preferred Medication Changes.
    Ann Allergy Asthma Immunol. 2022 May 21. pii: S1081-1206(22)00448.
    >> Share

  180. SHERREY J, Biggs S, Dorrian J, Martin J, et al
    Allergic disease, sleep problems and psychological distress in children recruited from the general community.
    Ann Allergy Asthma Immunol. 2022 May 19. pii: S1081-1206(22)00409.
    >> Share

  181. MENDY A, Mersha TB
    Comorbidities in Childhood-onset and Adult-Onset Asthma.
    Ann Allergy Asthma Immunol. 2022 May 17. pii: S1081-1206(22)00410.
    >> Share

  182. POLINSKI KJ, Bell GA, Trinh MH, Sundaram R, et al
    Maternal obesity, gestational weight gain and offspring asthma and atopy.
    Ann Allergy Asthma Immunol. 2022 May 9. pii: S1081-1206(22)00397.
    >> Share

  183. WILSON K, Gebretsadik T, Adgent MA, Loftus C, et al
    The association between duration of breastfeeding and childhood asthma outcomes.
    Ann Allergy Asthma Immunol. 2022 May 9. pii: S1081-1206(22)00400.
    >> Share

  184. YAMANE M, Ohnishi H, Tsuji K, Anabuki K, et al
    Dupilumab-induced peripheral neuropathy in a patient with severe asthma.
    Ann Allergy Asthma Immunol. 2022;128:611.
    >> Share

  185. GALANT SP, Morphew T, Ehwerhemuepha L
    Reduced exposure to respiratory viral triggers may explain less health care utilization for children with asthma.
    Ann Allergy Asthma Immunol. 2022;128:486-487.
    >> Share

  186. WHITE AA
    If aspirin-exacerbated respiratory disease treatment is a jigsaw puzzle, where do the aspirin and biologic pieces go?
    Ann Allergy Asthma Immunol. 2022;128:484-485.
    >> Share

  187. GRAYSON MH
    New! American College of Allergy, Asthma and Immunology Annals fellow-in-training award program.
    Ann Allergy Asthma Immunol. 2022;128:483.
    >> Share

  188. SPERGEL BL, Ruffner MA, Godwin BC, Liacouras CA, et al
    Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use.
    Ann Allergy Asthma Immunol. 2022;128:589-593.
    >> Share

    April 2022
  189. HASAN ARSHAD S
    Does allergen Immunotherapy for allergic rhinitis prevent asthma?
    Ann Allergy Asthma Immunol. 2022 Apr 29. pii: S1081-1206(22)00392.
    >> Share

  190. WONG M, Forno E, Celedon JC
    Asthma: interactions between obesity and other risk factors.
    Ann Allergy Asthma Immunol. 2022 Apr 29. pii: S1081-1206(22)00394.
    >> Share

  191. NIESSEN NM, Fricker M, McDonald VM, Gibson PG, et al
    T2-low: What do we know? - Past, present, and future of biologic therapies in non-eosinophilic asthma.
    Ann Allergy Asthma Immunol. 2022 Apr 26. pii: S1081-1206(22)00342.
    >> Share

  192. CIPRANDI G, Schiavetti I, Cioffi L, Pane M, et al
    The PRObiotics in Pediatric Asthma Management (PROPAM) study: a post-hoc analysis in allergic children.
    Ann Allergy Asthma Immunol. 2022 Apr 26. pii: S1081-1206(22)00391.
    >> Share

  193. ELDEIRAWI KM, Nyenhuis SM, Huntington-Moskos L, Polivka BJ, et al
    COVID-19 Related Anxiety Is Associated with Uncontrolled Asthma in Adults.
    Ann Allergy Asthma Immunol. 2022 Apr 22. pii: S1081-1206(22)00308.
    >> Share

  194. WINSLOW A, Keet C
    Preventing Allergies Through the Skin.
    Ann Allergy Asthma Immunol. 2022 Apr 22. pii: S1081-1206(22)00311.
    >> Share

  195. ZHANG H, Xian M, Shi X, Luo T, et al
    Blocking function of allergen-specific IgG, F(ab')2, and Fab antibodies prepared from patients undergoing Dermatophagoides pteronyssinus immunotherapy.
    Ann Allergy Asthma Immunol. 2022 Apr 8. pii: S1081-1206(22)00293.
    >> Share

  196. ALABDULKARIM N, Gai J, Bost J, Pillai D, et al
    Effect of the COVID-19 pandemic on morbidity among children hospitalized for an asthma exacerbation.
    Ann Allergy Asthma Immunol. 2022 Apr 7. pii: S1081-1206(22)00294.
    >> Share

  197. CROPPER KJ, Davis BE, Cockcroft DW
    Effect of daily tiotropium on allergen-induced early asthmatic responses and airway inflammation.
    Ann Allergy Asthma Immunol. 2022 Apr 5. pii: S1081-1206(22)00296.
    >> Share

  198. OPPENHEIMER J, Leung DYM
    Asthma 2022-moving toward precision medicine.
    Ann Allergy Asthma Immunol. 2022;128:343.
    >> Share

  199. BORISH L
    Rethinking the central role of mast cells in virally-mediated asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Apr 1. pii: S1081-1206(22)00288.
    >> Share

  200. MISS OZUNA L, Ryan T, Bensko JC, Laidlaw TM, et al
    Dupilumab-associated arthralgia in patients with aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2022;128:469-472.
    >> Share

    March 2022
  201. HOWELL D, Rogers L, Kasarskis A, Twyman K, et al
    Comparison and Validation of Algorithms for Asthma Diagnosis in an Electronic Medical Record System.
    Ann Allergy Asthma Immunol. 2022 Mar 30. pii: S1081-1206(22)00285.
    >> Share

  202. MACDONALD M, Chang WC, Martin LJ, Hershey GKK, et al
    The Pediatric Asthma Risk Score (PARS): more does not mean better.
    Ann Allergy Asthma Immunol. 2022 Mar 29. pii: S1081-1206(22)00284.
    >> Share

  203. KIMURA H, Shimizu K, Tanabe N, Makita H, et al
    Further evidence for association of YKL-40 with severe asthma airway remodeling.
    Ann Allergy Asthma Immunol. 2022 Mar 24. pii: S1081-1206(22)00207.
    >> Share

  204. LUDWIG A, Brehm C, Fung C, Jia S, et al
    Asthma and COVID-19 related outcomes in hospitalized patients: A single center experience.
    Ann Allergy Asthma Immunol. 2022 Mar 24. pii: S1081-1206(22)00208.
    >> Share

  205. OPPENHEIMER J, Hoyte FCL, Phipatanakul W, Silver J, et al
    Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions.
    Ann Allergy Asthma Immunol. 2022 Mar 7. pii: S1081-1206(22)00170.
    >> Share

  206. ADEJUMO I, Patel M, McKeever TM, Shaw DE, et al
    Does inhaler technology improve adherence and asthma control? A pilot randomised controlled trial.
    Ann Allergy Asthma Immunol. 2022 Mar 4. pii: S1081-1206(22)00169.
    >> Share

  207. WANG Y, Guo D, Chen X, Wang S, et al
    Trends in asthma among adults in the United States, NHANES 2005-2018.
    Ann Allergy Asthma Immunol. 2022 Mar 4. pii: S1081-1206(22)00168.
    >> Share

  208. PATEL P, Bensko JC, Bhattacharyya N, Laidlaw TM, et al
    Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2022;128:326-328.
    >> Share

    February 2022
  209. KOINIS-MITCHELL D, D'Angelo C, Dunsiger S, McQuaid E, et al
    Effects of COVID-19 Pandemic on Children, Adolescents and Young Adults with Asthma in Rhode Island: Patterns in Emergency Department Utilization with Geospatial Mapping.
    Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00120.
    >> Share

  210. MACIAG MC, Phipatanakul W
    Update on Indoor Allergens and Their Impact on Pediatric Asthma.
    Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00119.
    >> Share

  211. RAMEY OL, Silva Almodovar A, Nahata MC
    Medication Adherence in Medicare Enrolled Older Adults with Asthma Before and During the COVID-19 Pandemic.
    Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00121.
    >> Share

  212. MELHORN DJ, Howell DI, Pavord PID
    Should we apply a treatable traits approach to asthma care?
    Ann Allergy Asthma Immunol. 2022 Feb 13. pii: S1081-1206(22)00098.
    >> Share

  213. SEHAYEK D, Gold MS, Gabrielli S, Abrams EM, et al
    Seafood-Induced Anaphylaxis in Children Presenting to Canadian Emergency Departments: Rates, Clinical Presentation and Management.
    Ann Allergy Asthma Immunol. 2022 Feb 13. pii: S1081-1206(22)00097.
    >> Share

  214. ENG V, Moreno GP, Chang J, Liebhaber M, et al
    A Pediatric Asthma Camp Experience during the COVID-19 Pandemic.
    Ann Allergy Asthma Immunol. 2022 Feb 4. pii: S1081-1206(22)00087.
    >> Share

  215. MULLUR J, Steger CM, Gakpo D, Bensko JC, et al
    Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease: Efficacy, tolerability, and patient experience.
    Ann Allergy Asthma Immunol. 2022 Feb 4. pii: S1081-1206(22)00090.
    >> Share

  216. CHIPPS BE, Murphy KR, Wise RA, McCann WA, et al
    Assessing Construct Validity of the Asthma Impairment and Risk Questionnaire Using a 3-month Exacerbation Recall.
    Ann Allergy Asthma Immunol. 2022 Feb 2. pii: S1081-1206(22)00081.
    >> Share

  217. GUILBERT TW, Biagini JM, Ramsey RR, Keidel K, et al
    Treatment by Biomarker-Informed Endotype Versus Guideline Care in Children with Difficult to Treat Asthma.
    Ann Allergy Asthma Immunol. 2022 Feb 2. pii: S1081-1206(22)00076.
    >> Share

    January 2022
  218. STOUT S, Murphy H, Pandya A, Yeh HW, et al
    The Effect of COVID-19 on Asthma Visits.
    Ann Allergy Asthma Immunol. 2022 Jan 28. pii: S1081-1206(22)00048.
    >> Share

  219. GENG B, Dixon AE, Ko J, Janampally P, et al
    Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma.
    Ann Allergy Asthma Immunol. 2022 Jan 28. pii: S1081-1206(22)00045.
    >> Share

  220. WANG E, Wechsler ME
    A Rational Approach to Compare and Select Biologic Therapeutics in Asthma.
    Ann Allergy Asthma Immunol. 2022 Jan 27. pii: S1081-1206(22)00046.
    >> Share

  221. POPOV TA, Hristova D, Kralimarkova TZ, Mustakov TB, et al
    Time course of disease characteristics in subjects with severe allergic asthma starting treatment with omalizumab.
    Ann Allergy Asthma Immunol. 2022 Jan 24. pii: S1081-1206(22)00024.
    >> Share

  222. DROUIN O, Smyrnova A, Betinjane N, Ducharme FM, et al
    Adherence to inhaled corticosteroids prescribed once- vs twice-daily in children with asthma.
    Ann Allergy Asthma Immunol. 2022 Jan 22. pii: S1081-1206(22)00022.
    >> Share

  223. MUISER S, Gosens R, van den Berge M, Kerstjens HAM, et al
    Understanding the role of long-acting muscarinic antagonists in asthma treatment.
    Ann Allergy Asthma Immunol. 2022 Jan 21. pii: S1081-1206(22)00017.
    >> Share

  224. ESCHENBACHER W, Kim M, Mattos J, Lawrence M, et al
    Activation of platelet-adherent basophils in chronic rhinosinusitis with alcohol hypersensitivity.
    Ann Allergy Asthma Immunol. 2022 Jan 18. pii: S1081-1206(22)00014.
    >> Share

  225. FENG X, Lawrence MG, Payne SC, Mattos J, et al
    Lower viral loads in rhinovirus-challenged allergic subjects despite reduced innate immunity.
    Ann Allergy Asthma Immunol. 2022 Jan 12. pii: S1081-1206(22)00010.
    >> Share

  226. VISWAM D, Mansur AH
    Mode of onset and triggers of severe asthma; the severe asthma clinic perspective.
    Ann Allergy Asthma Immunol. 2022 Jan 11. pii: S1081-1206(22)00008.
    >> Share

  227. WONG M, Han YY, Rosser F, Acosta-Perez E, et al
    Persistent overweight or obesity, lung function, and asthma exacerbations in Puerto Rican Youth.
    Ann Allergy Asthma Immunol. 2022 Jan 8. pii: S1081-1206(22)00005.
    >> Share

  228. LOBATO M, Gaspar-Marques J, Carreiro-Martins P, Pinto PL, et al
    Secondary adrenal suppression related to high doses of inhaled corticosteroids in severe asthma patients.
    Ann Allergy Asthma Immunol. 2022 Jan 7. pii: S1081-1206(22)00002.
    >> Share

  229. BACHARIER LB
    Asthma Guidelines: Where to next?: A Perspective for Annals of Allergy, Asthma & Immunology.
    Ann Allergy Asthma Immunol. 2022 Jan 5. pii: S1081-1206(21)01342.
    >> Share

  230. WANG E, Zahid S, Moudgal AN, Demaestri S, et al
    Intimate Partner Violence and Asthma in Pediatric and Adult Populations: A Systematic Review.
    Ann Allergy Asthma Immunol. 2022 Jan 4. pii: S1081-1206(21)01343.
    >> Share

  231. LAWRENCE MG, Teague WG, Feng X, Welch C, et al
    Interleukin-5 receptor alpha (CD125) expression on human blood and lung neutrophils.
    Ann Allergy Asthma Immunol. 2022;128:53-60.
    >> Share

    December 2021
  232. BURROWS AG, Ellis AK
    Psychological Impacts of COVID-19 on people with Asthma, Allergic Rhinitis and Food Allergy.
    Ann Allergy Asthma Immunol. 2021 Dec 28. pii: S1081-1206(21)01310.
    >> Share

  233. FISCHELL SZ, Fischell JM, Olexa G, Callahan C, et al
    Impact of COVID-19 pandemic on frequency and severity of asthma exacerbations in an inner-city population.
    Ann Allergy Asthma Immunol. 2021 Dec 16. pii: S1081-1206(21)01308.
    >> Share

    November 2021
  234. CORREN J, Silver J, Molfino NA, Bogart M, et al
    A real-world study of ICS use in patients with severe eosinophilic asthma treated with mepolizumab.
    Ann Allergy Asthma Immunol. 2021 Nov 10. pii: S1081-1206(21)01219.
    >> Share

  235. LU MA, Eckmann T, Ruvalcaba E, McQuaid EL, et al
    Family Management of Asthma in Head Start Preschool Children.
    Ann Allergy Asthma Immunol. 2021 Nov 10. pii: S1081-1206(21)01217.
    >> Share

  236. CARR TF
    Treatment approaches for the patient with T2 low asthma.
    Ann Allergy Asthma Immunol. 2021;127:530-535.
    >> Share

  237. OPPENHEIMER JJ, Leung DYM
    Asthma, in quest of optimizing care.
    Ann Allergy Asthma Immunol. 2021;127:517.
    >> Share

  238. LEVERONE N, Tran S, Barry J, Akuthota P, et al
    Diagnoses associated with peripheral blood eosinophilia: A 5-year review.
    Ann Allergy Asthma Immunol. 2021;127:597-598.
    >> Share

    October 2021
  239. LAFORCE C, Chipps BE, Albers FC, Reilly L, et al
    Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study.
    Ann Allergy Asthma Immunol. 2021 Oct 23. pii: S1081-1206(21)01169.
    >> Share

  240. GRANT T, Croce E, Matsui E
    Asthma and the Social Determinants of Health.
    Ann Allergy Asthma Immunol. 2021 Oct 18. pii: S1081-1206(21)01132.
    >> Share

  241. AVDEEV SN, Pozdnakova AA, Gaynitdinova VV, Chikina SY, et al
    Asthma in older adults with severe COVID-19: clinical outcomes and predictors of mortality.
    Ann Allergy Asthma Immunol. 2021 Oct 17. pii: S1081-1206(21)01163.
    >> Share

  242. HOSSAIN R, Zhao F, Michenkova M, Kaelber D, et al
    Trends in racial disparities in asthma emergency department utilization during COVID-19.
    Ann Allergy Asthma Immunol. 2021 Oct 12. pii: S1081-1206(21)01159.
    >> Share

  243. TORRE AB, Dasgupta R, Eldeirawi KM, Nyenhuis SM, et al
    Positive associations of pollutants and aeroallergens with allergic rhinitis in adults with asthma.
    Ann Allergy Asthma Immunol. 2021 Oct 11. pii: S1081-1206(21)01157.
    >> Share

  244. STAMPFLI M, Frei R, Divaret-Chauveau A, Schmausser-Hechfellner E, et al
    Inverse associations between food diversity in the 2(nd) year of life and allergic diseases.
    Ann Allergy Asthma Immunol. 2021 Oct 11. pii: S1081-1206(21)01154.
    >> Share

  245. BLEECKER ER, Gandhi H, Gilbert I, Murphy KR, et al
    Mapping Geographic Variability of Severe Uncontrolled Asthma in the United States: Management Implications.
    Ann Allergy Asthma Immunol. 2021 Oct 7. pii: S1081-1206(21)01125.
    >> Share

    September 2021
  246. LAM RW, Inselman JW, Jeffery MM, Maddux JT, et al
    National decline in asthma exacerbations in US during COVID19 pandemic.
    Ann Allergy Asthma Immunol. 2021 Sep 25. pii: S1081-1206(21)01113.
    >> Share

  247. SACO T, Ugalde IC, Cardet JC, Casale TB, et al
    Strategies for choosing a biologic for your patient with allergy or asthma.
    Ann Allergy Asthma Immunol. 2021 Sep 23. pii: S1081-1206(21)01035.
    >> Share

    July 2021
  248. BALL L, Velasquez SA, Jammal OMA, White AA, et al
    Atypical Eosinophilic Granulomatosis with Polyangiitis with Spontaneous Aspirin Reactivity and IgE Mediated Anaphylaxis.
    Ann Allergy Asthma Immunol. 2021 Jul 14. pii: S1081-1206(21)00502.
    >> Share

  249. UDOKO M, De Keyser H, Szefler SJ
    Should Asthmatic Children Simply be Treated as Little Adults?
    Ann Allergy Asthma Immunol. 2021 Jul 11. pii: S1081-1206(21)00498.
    >> Share

  250. FINEMAN S, Lee G, Hernandez-Truillo V, Chipps BE, et al
    From the Pages of Allergy Watch.
    Ann Allergy Asthma Immunol. 2021 Jul 8. pii: S1081-1206(21)00490.
    >> Share

    May 2021
  251. ABRAMS EM, Greenhawt M, Shaker M, Kosowan L, et al
    Primary Care Provider-Reported Prevalence of Vaccine and Polyethylene-Glycol Allergy in Canada.
    Ann Allergy Asthma Immunol. 2021 May 15. pii: S1081-1206(21)00357.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016